Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf
Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drug Ozempic
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price negotiations, federal health officials announced Friday. At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
Biden Adds Ozempic to Medicare Price Renegotiation Talks
Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.
Ozempic, Ibrance among next drugs picked by Medicare for price talks
Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.
Ozempic and Wegovy among drugs on Medicare list getting price cuts
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than $200 billion over a decade.
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
15 New Drugs Selected for Medicare Price Negotiations
The bad news is people on Medicare will have to wait a while before they see the savings. Retirees could feel the economic impact of President-elect Donald Trump prepares to reclaim office in Washington,
Biden administration adds 15 drugs to Medicare price negotiation list
Medicare enrollees, however, still won’t be able to access the drugs for obesity under a federal law that prohibits the program from paying for weight loss treatments. Right now
Musk, Ramaswamy ready to go to war with seniors. Trump won't save Social Security. | Letters
Letters: Musk, Ramaswamy will declare war on seniors. Developing good citizens is the key to our future. Democrats should ...
Donald Trump and Social Security: 10 Things You Need to Know
Like most elected officials, Donald Trump recognizes that Social Security is vital to the financial well-being of our ...
Investor's Business Daily on MSN16h
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
What Is Agenda47? What To Know About Trump’s Policy Agenda Before His Inauguration
Education: Trump’s proposals for K-12 schools include having parents elect school principals, cutting federal funding to any ...
Gallup: Many Americans skeptical about Trump helping lower cost of healthcare
President-elect Donald Trump faces deep skepticism that his administration's policies will make health care more affordable, ...
WHDH20h
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
The Telegraph5h
CBO projects US debt to grow $23.9 trillion in 10 years, not including costs of extending tax cuts
The national debt is slated to rise by $23.9 trillion over the next decade, a sum that does not include trillions of dollars ...
5 years of the COVID-19 pandemic, the return of Trump and the war on public health
Trump returns to the White House as the tenth wave of the COVID-19 pandemic once again inundates hospitals, while the last ...